Leonteq Securities’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.76K Hold
361
– – ﹤0.01% 1129
2026
Q2
$2.25K Sell
361
-678
-65% -$2.93K ﹤0.01% 1137
2026
Q1
$2.94K Hold
1,039
– – ﹤0.01% 1148
2025
Q4
$3.38K Hold
1,039
– – ﹤0.01% 1285
2025
Q3
$2.98K Buy
+1,039
New +$2.65K ﹤0.01% 1200
2023
Q2
– Sell
-379
Closed -$5.31K – 1281
2023
Q1
$5.31K Sell
379
-31
-8% -$445 ﹤0.01% 1097
2022
Q4
$5.87K Sell
410
-38
-8% -$598 ﹤0.01% 1120
2022
Q3
$11.4K Hold
448
– – ﹤0.01% 1038
2022
Q2
$12.7K Sell
448
-2,046
-82% -$64.8K ﹤0.01% 1047
2022
Q1
$88K Buy
2,494
+2,000
+405% +$67K ﹤0.01% 757
2021
Q4
$20.7K Sell
494
-2,506
-84% -$102K ﹤0.01% 1039
2021
Q3
$147K Hold
3,000
– – 0.01% 646
2021
Q2
$125K Hold
3,000
– – 0.01% 674
2021
Q1
$107K Buy
3,000
+1,000
+50% +$33.1K 0.01% 667
2020
Q4
$56.1K Buy
+2,000
New +$55.7K ﹤0.01% 763

Other funds holding MRVI

Leonteq Securities's MRVI Position: Q3 2026 in Review

Leonteq Securities held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 361 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Leonteq Securities first reported a position in MRVI in Q4 2020 and has held it in 15 quarters since. The position peaked at $147K in Q3 2021. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Leonteq Securities held 361 shares of Maravai LifeSciences worth $2.76K as of Q3 2026.
  • Leonteq Securities left its Maravai LifeSciences share count unchanged in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1129 holding.
  • Leonteq Securities first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 15 quarters since.
  • Leonteq Securities's Maravai LifeSciences position peaked at $147K in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.